Cargando…
Amiodarone and risk of liver cirrhosis: a nationwide, population-based study
BACKGROUND: Liver cirrhosis is an uncommon but not rare side effect of amiodarone-induced hepatotoxicity. Patients with hepatitis B virus and hepatitis C virus infections are at a high risk for developing liver cirrhosis. However, the relationship between this treatment and risk of liver cirrhosis i...
Autores principales: | Huang, Ching-Hui, Lai, Ya-Yun, Kuo, Yu-Jui, Yang, Su-Ching, Chang, Yu-Jun, Chang, Kuo-Kuan, Chen, Wen-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330968/ https://www.ncbi.nlm.nih.gov/pubmed/30666120 http://dx.doi.org/10.2147/TCRM.S174868 |
Ejemplares similares
-
Amiodarone-Induced Liver Injury and Cirrhosis
por: Buggey, Jonathan, et al.
Publicado: (2015) -
Evaluation of nephroprotection of silymarin on contrast-induced nephropathy in liver cirrhosis patients: A population-based cohort study
por: Kuo, Yu-Jui, et al.
Publicado: (2018) -
Amiodarone-Induced Cirrhosis of Liver: What Predicts Mortality?
por: Hussain, Nasir, et al.
Publicado: (2013) -
Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases: A Nationwide Population-Based Dynamic Cohort Study in Taiwan
por: Yu, Kuang-Hui, et al.
Publicado: (2016) -
Amiodarone Use Is Associated With Increased Risk of Stroke in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study
por: Chen, Wei-Chun, et al.
Publicado: (2015)